Inhibition of intestinal adenoma formation in APC Min/+ mice by riccardin D, a natural product derived from liverwort plant dumortiera hirsuta

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Liu, Hui Ping ^a   Gao, Zu Hua ^b   Cui, Shu Xiang ^c   Sun, De Fu ^a   Wang, Yan ^c   Zhao, Cui Rong ^a   Lou, Hong Xiang ^a   Qu, Xian Jun ^a  

^a SHANDONG UNIVERSITY   (China)

^b CALGARY LABORATORY SERVICES   (Canada)

^c SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIBENZYL DERIVATIVE; MACROCYCLIC BISBIBENZYL DERIVATIVE; PLANT MEDICINAL PRODUCT; RICCARDIN D; UNCLASSIFIED DRUG; WNT PROTEIN; APC PROTEIN; BETA CATENIN; BIOLOGICAL PRODUCT; CASPASE; CYCLIN D1; CYCLOOXYGENASE 2; DIPHENYL ETHER DERIVATIVE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PTGS2 PROTEIN, MOUSE; STILBENE DERIVATIVE;

ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; APC GENE; APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CELL PROLIFERATION; COLON; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG STRUCTURE; DUMORTIERA HIRSUTA; ENZYME REPRESSION; FEMALE; HISTOPATHOLOGY; INTESTINE POLYP; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; SMALL INTESTINE; TREATMENT RESPONSE; TUMOR SUPPRESSOR GENE; ADENOMA; ANIMAL; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; INFLAMMATION; INTESTINE TUMOR; LIVERWORT; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PRECANCER; VASCULARIZATION;

ANIMALIA; DUMORTIERA HIRSUTA; MUS;

ADENOMA; ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; APOPTOSIS; BETA CATENIN; BIOLOGICAL AGENTS; CASPASES; CELL PROLIFERATION; COLON; CYCLIN D1; CYCLOOXYGENASE 2; HEPATOPHYTA; INFLAMMATION; INTESTINAL NEOPLASMS; INTESTINAL POLYPS; INTESTINE, SMALL; MICE; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PHENYL ETHERS; PRECANCEROUS CONDITIONS; SIGNAL TRANSDUCTION; STILBENES;

EID: 84863297741     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0033243     Document Type: Article

References (40)

1. Charalambous MP, Lightfoot T, Speirs V, Horgan K, Gooderham NJ, (2009) Expression of COX-2, NF-κB-p65, NF-κB-p50 and IKKα in malignant and adjacent normal human colorectal tissue. Br J Cancer 101: 106-115.
2. Terzić J, Grivennikov S, Karin E, Karin M, (2010) Inflammation and colon cancer. Gastroenterology 138: 2101-2114.
3. Cunningham D, Atkin W, Lenz HJ, Lynch HT, Minsky B, et al. (2010) Colorectal cancer. Lancet 375: 1030-1047.
4. Nishisho I, Nakamura Y, Miyoshi Y, Miki Y, Ando H, et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665-669.
5. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589-600.
6. Kwong LN, Dove WF, (2009) APC and its modifiers in colon cancer. Adv Exp Med Biol 656: 85-106.
7. McCart AE, Vickaryous NK, Silver A, (2008) Apc mice: models, modifiers and mutants. Pathol Res Pract 204: 479-490.
8. Yamada Y, Mori H, (2007) Multistep carcinogenesis of the colon in ApcMin/+ mouse. Cancer Sci 98: 6-10.
9. Lu ZQ, Fan PH, Ji M, Lou HX, (2006) Terpenoids and bisbibenzyls from Chinese liverworts Conocephalum conicum and Dumortiera hirsute. J Asian Nat Prod Res 8: 187-192.
10. Cheng A, Sun L, Wu X, Lou H, (2009) The inhibitory effect of a macrocyclic bisbibenzyl riccardin D on the biofilms of Candida albicans. Biol Pharm Bull 32: 1417-1421.
11. Xue X, Qu XJ, Gao ZH, Sun CC, Liu HP, et al. (2010) Riccardin D, a novel macrocyclic bisbibenzyl, induces apoptosis of human leukemia cells by targeting DNA topoisomerase II. Invest New Drugs doi:10.1007/s10637-010-9554-8.
12. Sun CC, Zhang YS, Xue X, Cheng YN, Liu HP, et al. (2011) Inhibition of angiogenesis involves in anticancer activity of riccardin D, a macrocyclic bisbibenzyl, in human lung carcinoma. Eur J Pharmacol 667: 136-143.
13. Guillen-Ahlers H, Suckow MA, Castellino FJ, Ploplis VA, (2010) Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden. PLoS ONE 5: e9070.
14. Xing J, Lv B, Xie C, Qu J, Lou H, (2008) Liquid chromatography-tandem mass spectrometry assay for the quantitation of plagiochin E and its main metabolite plagiochin E glucuronides in rat plasma. J Pharm Biomed Anal 47: 949-953.
15. Rajamanickam S, Velmurugan B, Kaur M, Singh RP, Agarwal R, (2010) Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin. Cancer Res 70: 2368-2378.
16. Hu R, Khor TO, Shen G, Jeong WS, Hebbar V, et al. (2006) Cancer chemoprevention of intestinal polyposis in ApcMin/+ mice by sulforaphane, a natural product derived from cruciferous vegetable. Carcinogenesis 27: 2038-2046.
17. Shen G, Khor TO, Hu R, Yu S, Nair S, et al. (2007) Chemoprevention of familial adenomatous polyposis by natural dietary compounds sulforaphane and dibenzoylmethane alone and in combination in ApcMin/+ mouse. Cancer Res 67: 9937-9944.
18. Lee SH, Hu LL, Gonzalez-Navajas J, Seo GS, Shen C, et al. (2010) ERK activation drives intestinal tumorigenesis in Apcmin/+ mice. Nat Med 16: 665-670.
19. An YT, Zhao Z, Sheng YC, Min Y, Xia YY, (2011) Therapeutic time window of YGY-E neuroprotection of cerebral ischemic injury in rats. Drug Discov Ther 5: 76-83.
20. Liu J, Li X, Cheng YN, Cui SX, Chen MH, et al. (2007) Inhibition of human gastric carcinoma cell growth by treatment of N(3)-o-toluyl-fluorouracil as a precursor of 5-fluorouracil. Eur J Pharmacol 574: 1-7.
21. Liu J, Li X, Cheng YN, Cui SX, Chen MH, et al. (2008) Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells. Life Sci 83: 815-820.
22. Seno H, Oshima M, Ishikawa TO, Oshima H, Takaku K, et al. (2002) Cyclooxygenase 2- and prostaglandin E(2) receptor EP(2)-dependent angiogenesis in Apc(Delta716) mouse intestinal polyps. Cancer Res 62: 506-511.
23. Park EJ, Shin JH, Seo YS, Kim DW, Hong SY, et al. (2011) Gonadotropin-releasing hormone-agonist induces apoptosis of human granulosa-luteal cells via caspase-8,-9 and-3, and poly-(ADP-ribose)-polymerase cleavage. Biosci Trends 5: 120-128.
24. He H, Xia HH, Wang JD, Gu Q, Lin MC, et al. (2006) Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma. Cancer 106: 1243-1249.
25. Wu WK, Sung JJ, Lee CW, Yu J, Cho CH, (2010) Cyclooxygenase-2 in tumorigenesis of gastrointestinal cancers: an update on the molecular mechanisms. Cancer Lett 295: 7-16.
26. Asakawa Y, Toyota M, Tori M, Hashimoto T, (2000) Chemical structures of macrocyclic bis(bibenzyls) isolated from liverworts (Hepaticae). Spectroscopy 14: 149-175.
27. Shi YQ, Zhu CJ, Yuan HQ, Li BQ, Gao J, et al. (2009) Marchantin C, a novel microtubule inhibitor from liverwort with anti-tumor activity both in vivo and in vitro. Cancer Lett 276: 160-170.
28. Wu XZ, Cheng AX, Sun LM, Sun SJ, Lou HX, (2009) Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans. Biochim Biophys Acta 1790: 770-777.
29. Guillen-Ahlers H, Buechler SA, Suckow MA, Castellino FJ, Ploplis VA, (2008) Sulindac treatment alters collagen and matrilysin expression in adenomas of ApcMin/+ mice. Carcinogenesis 29: 1421-1427.
30. Fearnhead NS, Britton MP, Bodmer WF, (2001) The ABC of APC. Hum Mol Genet 10: 721-733.
31. Greenspan EJ, Nichols FC, Rosenberg DW, (2010) Molecular alterations associated with sulindac-resistant colon tumors in ApcMin/+ mice. Cancer Prev Res (Phila) 3: 1187-1197.
32. Kuniyasu H, Luo Y, Fujii K, Sasahira T, Moriwaka Y, et al. (2010) CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver. Gut 59: 348-356.
33. Mladenova D, Daniel JJ, Dahlstrom JE, Bean E, Gupta R, et al. (2011) The NSAID sulindac is chemopreventive in the mouse distal colon but carcinogenic in the proximal colon. Gut 60: 350-360.
34. Carothers AM, Davids JS, Damas BC, Bertagnolli MM, (2010) Persistent cyclooxygenase-2 inhibition downregulates NF-{kappa}B, resulting in chronic intestinal inflammation in the Min/+ mouse model of colon tumorigenesis. Cancer Res 70: 4433-4442.
35. Kumar A, Takada Y, Boriek AM, Aggarwal BB, (2004) Nuclear factor-kappaB: its role in health and disease. J Mol Med 82: 434-448.
36. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K, (2006) Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol 12: 1336-1345.
37. Axelsson H, Lönnroth C, Andersson M, Lundholm K, (2010) Mechanisms behind COX-1 and COX-2 inhibition of tumor growth in vivo. Int J Oncol 37: 1143-1152.
38. Wang D, Mann JR, DuBois RN, (2004) WNT and cyclooxygenase-2 cross-talk accelerates adenoma growth. Cell Cycle 3: 1512-1515.
39. Zak S, Treven J, Nash N, Gutierrez LS, (2008) Lack of thrombospondin-1 increases angiogenesis in a model of chronic inflammatory bowel disease. Int J Colorectal Dis 23: 297-304.
40. Easwaran V, Lee SH, Inge L, Guo L, Goldbeck C, et al. (2003) β-Catenin regulates vascular endothelial growth factor expression in colon cancer. Cancer Res 63: 3145-153.